Yancey, Kim B <br/><br/>
Commentary regarding clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study.  [electronic resource] 

 -  Dermatologic therapy   
 - 174-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1529-8019 
<br/><br/><label>Standard No.: </label>10.1111/dth.12198  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Dermatologic Agents--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Pemphigus--drug therapy<br/>Rituximab--administration & dosage